semaglutide and estrogen A new study found postmenopausal women on hormone therapy + lost ~33% more weight than those on semaglutide alone (16% vs 12% at 12 months) 📉 may boost how GLP‑1 FDA Warns on Certain Forms

reveal that GLP-1R agonistinduced weight loss requires GLP-1Rs in the CNS, while Secher et al

Reported observations include: Improved mobility Better recovery timelines Reduced dependency on long-term pain management strategies Conventional veterinary practice may remain cautious due to limited formal clinical data

The compounded drugs are not generics, nor do they go through the Food and Drug Administrations approval process

10.1016/S0304-3835(01)00383-4 Cleusix V, Lacroix C, Vollenweider S, Duboux M, Le Blay G: Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria